3D bioprinting and its potential impact on cardiac failure treatment: An industry perspective
3D printing technologies are emerging as a disruptive innovation for the treatment of patients in cardiac failure. The ability to create custom devices, at the point of care, will affect both the diagnosis and treatment of cardiac diseases. The introduction of bioinks containing cells and biomateria...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AIP Publishing LLC
2020-03-01
|
| Series: | APL Bioengineering |
| Online Access: | http://dx.doi.org/10.1063/1.5128371 |